<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04741802</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00107615</org_study_id>
    <nct_id>NCT04741802</nct_id>
  </id_info>
  <brief_title>TOPS for African American Breast Cancer Survivors</brief_title>
  <official_title>Feasibility and Acceptability of a Community-based Weight Loss Program Among African American Breast Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For women diagnosed with breast cancer, dietary, weight loss, and physical activity have been&#xD;
      linked with clinically significant weight loss; decreased risk of death; reduced risk of&#xD;
      breast cancer recurrence; fewer cardiovascular events; and improved physical function. The&#xD;
      objectives of these aims are to a) determine if the TOPS materials and format are possible&#xD;
      and accepted by overweight and obese African American breast cancer survivors; b) gather data&#xD;
      for sample size calculations for a larger future study.&#xD;
&#xD;
      To meet these aims, we will collect data to see if participants enjoyed the TOPS program and&#xD;
      suggestions for changes to the program to make it fit their needs. Other methods will measure&#xD;
      recruitment, retention, and weight change.&#xD;
&#xD;
      Aim 1: Examine the feasibility and acceptability of a national, low-cost, community-based,&#xD;
      peer-led, weight loss program (Take Off Pounds Sensibly, TOPS) for overweight and obese&#xD;
      African American breast cancer survivors in the local chapter of a national African American&#xD;
      breast cancer support group (Sisters Network Triangle North Carolina, SNTNC).&#xD;
&#xD;
      Aim 2: Assess the weight change of overweight and obese African American breast cancer&#xD;
      survivors after 6 months in the TOPS program to gather data for sample size calculations for&#xD;
      a future RCT.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 11, 2021</start_date>
  <completion_date type="Anticipated">August 17, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 17, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of invited women who attended the information session</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of women who attended the information session that joined the TOPS program</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of women who remained in the program for 12 weeks</measure>
    <time_frame>Up to 12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number women who remained in the program for 24 weeks</measure>
    <time_frame>Up to 24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in weight as measured by scale reading</measure>
    <time_frame>baseline, 3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Feasibility and Acceptability of the TOPS Program</condition>
  <arm_group>
    <arm_group_label>TOPS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>weight loss program (Take Off Pounds Sensibly, TOPS) for overweight and obese African American breast cancer survivors</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TOPS</intervention_name>
    <description>weight loss program (Take Off Pounds Sensibly, TOPS) for overweight and obese African American breast cancer survivors in the local chapter of a national African American breast cancer support group (Sisters Network Triangle North Carolina, SNTNC).</description>
    <arm_group_label>TOPS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women diagnosed with breast cancer with BMI â‰¥ 25 kg/m after completion of primary 2&#xD;
             therapy (surgery, radiation, adjuvant or neo-adjuvant chemotherapy).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women whose oncology providers do not agree with their participation in a weight loss&#xD;
             program or those participating in another weight loss program.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nia Mitchell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Health System</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 2, 2021</study_first_submitted>
  <study_first_submitted_qc>February 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 2, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/02/NCT04741802/Prot_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

